Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The role of the opioid system in controlling pain, reward and addiction is well established, but its role in regulating other emotional responses is poorly documented in pharmacology. The mu-, delta- and kappa- opioid receptors (encoded by Oprm, Oprd1 and Oprk1, respectively) mediate the biological activity of opioids. We have generated Oprd1-deficient mice and compared the behavioural responses of mice lacking Oprd1, Oprm (ref. 6) and Oprk1 (ref. 7) in several models of anxiety and depression. Our data show no detectable phenotype in Oprk1-/- mutants, suggesting that kappa-receptors do not have a role in this aspect of opioid function; opposing phenotypes in Oprm-/- and Oprd1-/- mutants which contrasts with the classical notion of similar activities of mu- and delta-receptors; and consistent anxiogenic- and depressive-like responses in Oprd1-/- mice, indicating that delta-receptor activity contributes to improvement of mood states. We conclude that the Oprd1-encoded receptor, which has been proposed to be a promising target for the clinical management of pain, should also be considered in the treatment of drug addiction and other mood-related disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, agonism of the delta-opioid receptor, the primary receptor target of enkephalin, promotes antidepressant outcomes (80), while delta receptor knockout promotes depressive-like behavior (81).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [81]
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
Self-citationOpioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,292
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Self-citationTimpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W. (1998) · Nature Genetics · doi:10.1038/520 · Cited by 919
Lufkin, T., Dierich, A., LeMeur, M., Mark, M., & Chambon, P. (1991) · Cell · doi:10.1016/0092-8674(91)90034-v · Cited by 697
Self-citationDecreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues
Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J.-M., Lüscher, B., & Mohler, H. (1999) · Nature Neuroscience · doi:10.1038/12207 · Cited by 550
Cited by
Items 101–200 of 692
The Flavonoid Glycosides, Myricitrin, Gossypin and Naringin Exert Anxiolytic Action in Mice
Fernández, S. P., Nguyen, M., Yow, T. T., Chu, C., Johnston, G. A. R., Hanrahan, J. R., & Chebib, M. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9969-9 · Cited by 122
Kremer, M., Yalçın, İ., Goumon, Y., Wurtz, X., Nexon, L., Daniel, D., Megat, S., Ceredig, R. A., Ernst, C., Turecki, G., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1004-18.2018 · Cited by 115
Belief or Need? Accounting for individual variations in the neurochemistry of the placebo effect
Zubieta, J.-K., Yau, W. W., Scott, D., & Stohler, C. S. (2005) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2005.08.006 · Cited by 123
Ikeda, Y., Kumagai, H., Skach, A., Sato, M., & Yanagisawa, M. (2013) · Cell · doi:10.1016/j.cell.2013.10.052 · Cited by 121
Martin, M., Matifas, A., Maldonado, R., & Kieffer, B. L. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02482.x · Cited by 110
Self-citationNarita, M., Kuzumaki, N., Narita, M., Kaneko, C., Hareyama, N., Miyatake, M., Shindo, K., Miyoshi, K., Nakajima, M., Nagumo, Y., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03824.x · Cited by 126
The opioid system in depression
Jelen, L. A., Stone, J. M., Young, A. H., & Mehta, M. A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104800 · Cited by 108
Delta-Opioid Receptors Are Critical for Tricyclic Antidepressant Treatment of Neuropathic Allodynia
Benbouzid, M., Gavériaux‐Ruff, C., Yalçın, İ., Waltisperger, E., Tessier, L., Muller, A., Kieffer, B. L., Freund‐Mercier, M. J., & Barrot, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.016 · Cited by 106
Self-citationPharmacology of N-desmethylclozapine☆
Lameh, J., Burstein, E. S., TAYLOR, E., Weiner, D. M., Vanover, K. E., & BONHAUS, D. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.05.004 · Cited by 106
Faster, better, stronger: Towards new antidepressant therapeutic strategies
O’Leary, O. F., Dinan, T. G., & Cryan, J. F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.046 · Cited by 115
Endogenous opioid systems alterations in pain and opioid use disorder
Higginbotham, J. A., Markovic, T., Massaly, N., & Morón, J. A. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.1014768 · Cited by 111
Broom, D. C., Jutkiewicz, E. M., Folk, J. E., Traynor, J. R., Rice, K. C., & Woods, J. H. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1179-y · Cited by 103
Saitoh, A., Sugiyama, A., Nemoto, T., Fujii, H., Wada, K., Oka, J., Nagase, H., & Yamada, M. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.041 · Cited by 111
Chefer, V. I., & Shippenberg, T. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.128 · Cited by 97
Piskorowski, R. A., & Chevaleyre, V. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.0649-13.2013 · Cited by 95
Lutz, P.-E., Ayranci, G., Chu-Sin-Chung, P., Matifas, A., Koebel, P., Filliol, D., Befort, K., Ouagazzal, A.-M., & Kieffer, B. L. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.126 · Cited by 92
Self-citationTargeting opioid dysregulation in depression for the development of novel therapeutics
Browne, C. A., & Lucki, I. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.009 · Cited by 95
Enkephalins: Endogenous Analgesics with an Emerging Role in Stress Resilience
Henry, M. S., Gendron, L., Tremblay, M.-E., & Drolet, G. (2017) · Neural Plasticity · doi:10.1155/2017/1546125 · Cited by 89
Control of hormonal stress reactivity by the endogenous opioid system
Bilkei‐Gorzó, A., Rácz, I., Michel, K., Mauer, D., Zimmer, A. M., Klingmüller, D., & Zimmer, A. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.12.010 · Cited by 110
Opioid receptor random mutagenesis reveals a mechanism for G protein–coupled receptor activation
Décaillot, F. M., Befort, K., Filliol, D., Yue, S. Y., Walker, P., & Kieffer, B. L. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb950 · Cited by 105
Self-citationIkeda, K., Kobayashi, T., Kumanishi, T., Yano, R., Sora, I., & Niki, H. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00094-9 · Cited by 113
Translational research in bipolar disorder: emerging insights from genetically based models
Chen, G., Henter, I. D., & Manji, H. K. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.3 · Cited by 95
Bushlin, I., Gupta, A., Stockton, S. D., Miller, L. K., & Devi, L. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049789 · Cited by 100
Enkephalin Disinhibits Mu Opioid Receptor-Rich Striatal Patches via Delta Opioid Receptors
Banghart, M. R., Neufeld, S. Q., Wong, N. C., & Sabatini, B. L. (2015) · Neuron · doi:10.1016/j.neuron.2015.11.010 · Cited by 95
Thörnqvist, P., McCarrick, S., Ericsson, M., Roman, E., & Winberg, S. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.06.017 · Cited by 97
The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
Aquino, J. P. D., Parida, S., & Sofuoglu, M. (2021) · Clinical Drug Investigation · doi:10.1007/s40261-021-01032-7 · Cited by 95
Nieto, M. M., Guen, S. L., Kieffer, B. L., Roques, B. P., & Noble, F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.025 · Cited by 93
Self-citationMu and Delta Opioid Receptors Oppositely Regulate Motor Impulsivity in the Signaled Nose Poke Task
Olmstead, M. C., Ouagazzal, A.-M., & Kieffer, B. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004410 · Cited by 90
Self-citationMeirsman, A. C., Merrer, J. L., Pellissier, L. P., Díaz, J., Clesse, D., Kieffer, B. L., & Becker, J. A. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.020 · Cited by 95
Self-citationMargolis, E. B., Fields, H. L., Hjelmstad, G. O., & Mitchell, J. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4569-08.2008 · Cited by 87
Huang, P., Xu, W., Yoon, S.-I., Chen, C., Chong, P. L., & Liu‐Chen, L. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.032 · Cited by 95
Vergura, R., Balboni, G., Spagnolo, B., Gavioli, E. C., Lambert, D. G., McDonald, J. L., Trapella, C., Lazarus, L. H., Regoli, D. C., Guerrini, R., et al. (2007) · Peptides · doi:10.1016/j.peptides.2007.10.012 · Cited by 90
Jutkiewicz, E. M., Rice, K. C., Traynor, J. R., & Woods, J. H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0138-9 · Cited by 96
Hirata, H., Sonoda, S., Agui, S., Yoshida, M., Ohinata, K., & Yoshikawa, M. (2007) · Peptides · doi:10.1016/j.peptides.2007.07.024 · Cited by 89
Laurent, V., Leung, B., Maidment, N., & Balleine, B. W. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4688-11.2012 · Cited by 86
Zarrindast, M., Babapoor-Farrokhran, S., Babapoor-Farrokhran, S., & Rezayof, A. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.03.020 · Cited by 91
Novel approaches to targeting neuropeptide systems
Roques, B. P. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01571-6 · Cited by 92
Naloxone fails to produce conditioned place aversion in μ-opioid receptor knock-out mice
Skoubis, P. D., Matthes, H. W. D., Walwyn, W. M., Kieffer, B. L., & Maidment, N. T. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00333-5 · Cited by 86
Self-citationContet, C., Gavériaux‐Ruff, C., Matifas, A., Caradec, C., Champy, M., & Kieffer, B. L. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300934 · Cited by 89
Self-citationGoody, R. J., Oakley, S. M., Filliol, D., Kieffer, B. L., & Kitchen, I. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02452-6 · Cited by 84
Self-citationGeneration of dynorphin knockout mice
Sharifi, N., Diehl, N. L., Yaswen, L. R., Brennan, M. B., & Hochgeschwender, U. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00264-3 · Cited by 84
An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans
Crist, R. C., Clarke, T., Ang, A., Ambrose‐Lanci, L. M., Lohoff, F. W., Saxon, A. J., Ling, W. W., Hillhouse, M. P., Bruce, R. D., WOODY, G. E., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.99 · Cited by 83
Scherrer, G., Befort, K., Contet, C., Becker, J. A. J., Matifas, A., & Kieffer, B. L. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03339.x · Cited by 83
Self-citationCarroll, F. I. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030092d · Cited by 83
The effects of trauma on brain and body: A unifying role for the midbrain periaqueductal gray
Terpou, B. A., Harricharan, S., McKinnon, M. C., Frewen, P., Jetly, R., & Lanius, R. A. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24447 · Cited by 82
Chao, D., Bazzy‐Asaad, A., Balboni, G., & Xia, Y. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21000 · Cited by 82
Nicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81
Zhang, H., Torregrossa, M. M., Jutkiewicz, E. M., Shi, Y., Rice, K. C., Woods, J. H., Watson, S. J., & Holden Ko, M. C. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04621.x · Cited by 81
Sauriyal, D. S., Jaggi, A. S., & Singh, N. (2011) · Neuropeptides · doi:10.1016/j.npep.2010.12.004 · Cited by 86
Endogenous opioids regulate moment-to-moment neuronal communication and excitability
Winters, B. L., Gregoriou, G. C., Kissiwaa, S. A., Wells, O., Medagoda, D. I., Hermes, S. M., Burford, N. T., Alt, A. J., Aicher, S. A., & Bagley, E. E. (2017) · Nature Communications · doi:10.1038/ncomms14611 · Cited by 80
GPR3 Receptor, a Novel Actor in the Emotional-Like Responses
Valverde, O., Célèrier, E., Baranyi, M., Vanderhaeghen, P., Maldonado, R. J., Sperlágh, B., Vassart, G., & Ledent, C. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004704 · Cited by 89
Self-citationNozaki, C., Bourdonnec, B. L., Reiss, D. J., Windh, R. T., Little, P., Dolle, R. E., Kieffer, B. L., & Gavériaux‐Ruff, C. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188987 · Cited by 79
Self-citationDifferential involvement of the Mu and Kappa opioid receptors in spatial learning
Jamot, L., Matthes, H. W. D., Simonin, F., Kieffer, B. L., & Roder, J. C. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00013.x · Cited by 78
Self-citationInvolvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats
Marı́n, S., Marco, E. M., Biscaia, M., Fernández, B., Rubio, M., Guaza, C., Schmidhammer, H., & Viveros, M. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)01041-9 · Cited by 78
Becker, J. A. J., Kieffer, B. L., & Le Merrer, J. (2017) · Addiction Biology · doi:10.1111/adb.12405 · Cited by 77
Self-citationThe Role of Amygdalar Mu-Opioid Receptors in Anxiety-Related Responses in Two Rat Models
Wilson, M. A., & Junor, L. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301675 · Cited by 76
Nadal, X., La Porta, C., Andreea Bura, S., & Maldonado, R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.077 · Cited by 76
Self-citationRichards, E. M., Mathews, D. C., Luckenbaugh, D. A., Ionescu, D. F., Machado-Vieira, R., Niciu, M. J., Duncan, W. C., Nolan, N. M., Franco-Chaves, J. A., Hudzik, T., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4195-4 · Cited by 76
Leukocyte opioid receptors mediate analgesia via Ca2+-regulated release of opioid peptides
Celik, M. Ö., Łabuz, D., Henning, K., Busch-Dienstfertig, M., Gavériaux‐Ruff, C., Kieffer, B. L., Zimmer, A., & Machelska, H. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.04.018 · Cited by 83
Self-citationMice lacking δ‐opioid receptors resist the development of diet‐induced obesity
Czyzyk, T. A., Romero‐Picó, A., Pintar, J., McKinzie, J. H., Tschöp, M. H., Statnick, M. A., & Nogueiras, R. (2012) · The FASEB Journal · doi:10.1096/fj.12-208041 · Cited by 71
Role of δ-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats
Saitoh, A., Yoshikawa, Y., Onodera, K., & Kamei, J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0112-6 · Cited by 80
Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds
Bilkei‐Gorzó, A., Rácz, I., Michel, K., Zimmer, A. M., Klingm�ller, D., & Zimmer, A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1904-9 · Cited by 78
Distribution of delta opioid receptor-expressing neurons in the mouse hippocampus
Erbs, E., Faget, L., Scherrer, G., Kessler, P., Hentsch, D., Vonesch, J.-L., Matifas, A., Kieffer, B. L., & Massotte, D. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.06.023 · Cited by 66
Self-citationZarrindast, M.-R., Sarahroodi, S., Arzi, A., Khodayar, M. J., Taheri-Shalmani, S., & Rezayof, A. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283123c83 · Cited by 68
Placebo-induced analgesia in an operant pain model in rats
Nolan, T. A., Price, D. D., Caudle, R. M., Murphy, N. P., & Neubert, J. K. (2012) · Pain · doi:10.1016/j.pain.2012.04.026 · Cited by 76
Vaccarino, A. L., & Kastin, A. J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00566-6 · Cited by 88
Analysis of [3H] bremazocine binding in single and combinatorial opioid receptor knockout mice
Simonin, F., Slowe, S. J., Becker, J. A. J., Matthes, H. W. D., Filliol, D., Chluba, J., Kitchen, I., & Kieffer, B. L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00822-6 · Cited by 84
Self-citationRezayof, A., Hosseini, S.-S., & Zarrindast, M. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.030 · Cited by 75
Bjørnebekk, A., Mathé, A. A., & Brené, S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300820 · Cited by 77
Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice
Castañé, A., Robledo, P., Matifas, A., Kieffer, B. L., & Maldonado, R. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02409.x · Cited by 67
Self-citationNoble, F., & Roques, B. P. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.2.145 · Cited by 69
FMRP Expression Levels in Mouse Central Nervous System Neurons Determine Behavioral Phenotype
Arsenault, J., Gholizadeh, S., Niibori, Y., Pacey, L. K. K., Halder, S. K., Koxhioni, E., Konno, A., Hirai, H., & Hampson, D. R. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.090 · Cited by 78
The δ-Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats
Torregrossa, M. M., Isgor, C., Folk, J. E., Rice, K. C., Watson, S. J., & Woods, J. H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300345 · Cited by 72
Merrer, J. L., Rezaï, X., Scherrer, G., Becker, J. A. J., & Kieffer, B. L. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.1 · Cited by 80
Self-citationRasmussen, D. D., Boldt, B. M., Wilkinson, C. W., & Mitton, D. R. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02572.x · Cited by 73
Modulation of alcohol and nicotine responses through the endogenous opioid system
Drews, E., & Zimmer, A. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.09.004 · Cited by 71
Monogenic mouse models of social dysfunction: Implications for autism
Oddi, D., Crusio, W. E., D'Amato, F. R., & Pietropaolo, S. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.002 · Cited by 70
Behavioral Effects of d-Opioid Receptor Agonists: Potential Antidepressants?
Broom, D. C., Jutkiewicz, E. M., Rice, K. C., Traynor, J. R., & Woods, J. H. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.90.1 · Cited by 76
Deletion of δ-opioid receptor in mice alters skin differentiation and delays wound healing
Bigliardi‐Qi, M., Gavériaux‐Ruff, C., Zhou, H., Hell, C., Bady, P., Rufli, T., Kieffer, B. L., & Bigliardi, P. L. (2006) · Differentiation · doi:10.1111/j.1432-0436.2006.00065.x · Cited by 66
Self-citationDual Efficacy of Delta Opioid Receptor-Selective Ligands for Ethanol Drinking and Anxiety
van Rijn, R. M., Brissett, D. I., & Whistler, J. L. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170969 · Cited by 68
Javelot, H., Messaoudi, M., Garnier, S., & Rougeot, C. (2010) · PubMed · Cited by 65
Opioids: Modulators of angiogenesis in wound healing and cancer
Ondrovics, M., Hoelbl‐Kovacic, A., & Fux, D. A. (2017) · Oncotarget · doi:10.18632/oncotarget.15419 · Cited by 67
Crist, R. C., Ambrose‐Lanci, L. M., Vaswani, M., Clarke, T., Zeng, A. M., Yuan, C., Ferraro, T. N., Hakonarson, H. H., Kampman, K. M., Dackis, C. A., et al. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.06.023 · Cited by 66
β‐Arrestin 2 dependence of δ opioid receptor agonists is correlated with alcohol intake
Chiang, T., Sansuk, K., & van Rijn, R. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13374 · Cited by 69
Koob, G. F., Roberts, A. J., Kieffer, B. L., Heyser, C. J., Katner, S. N., Ciccocioppo, R., & Weiss, F. (2002) · Springer eBooks · doi:10.1007/0-306-47939-7_19 · Cited by 66
Self-citationA role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors
Randall-Thompson, J., Pescatore, K. A., & Unterwald, E. M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1980-y · Cited by 61
The role of δ‐opioid receptors in learning and memory underlying the development of addiction
Klenowski, P. M., Morgan, M., & Bartlett, S. E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12618 · Cited by 70
The role of the dynorphin/κ opioid receptor system in anxiety
Hang, A., Wang, Y.-J., He, L., & Liu, J.-G. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.32 · Cited by 62
Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction
Shippenberg, T., LeFevour, A., & Chefer, V. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927813 · Cited by 58
Decreased response to social defeat stress in μ-opioid-receptor knockout mice
Komatsu, H., Ohara, A., Sasaki, K., Abe, H., Hattori, H., Hall, F. S., Uhl, G. R., & Sora, I. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.008 · Cited by 54
Chen, C., Lü, M., Pan, Q., Fichna, J., Zheng, L., Wang, K., Yu, Z., Li, Y., Li, K., Song, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145556 · Cited by 61
Chefer, V. I., Denoroy, L., Zapata, A., & Shippenberg, T. S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06827.x · Cited by 57
Bérubé, P., Laforest, S., Bhatnagar, S., & Drolet, G. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.04.009 · Cited by 63
Moye, L. S., Novack, M., Tipton, A. F., Krishnan, H. R., Pandey, S. C., & Pradhan, A. A. A. (2018) · Cephalalgia · doi:10.1177/0333102418777507 · Cited by 60
Bigliardi, P. L., Neumann, C., Teo, Y. L., Pant, A., & Bigliardi‐Qi, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12687 · Cited by 64
Nicotine anxiogenic and rewarding effects are decreased in mice lacking β-endorphin
Trigo, J. M., Zimmer, A., & Maldonado, R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.03.013 · Cited by 56
Self-citationA role for the mu opioid receptor in the antidepressant effects of buprenorphine
Robinson, S. A., Erickson, R. L., Browne, C. A., & Lucki, I. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.050 · Cited by 58
Ophuis, R. J. A. O., Boender, A. J., van Rozen, A. J., & Adan, R. A. H. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00014 · Cited by 59
Hauser, K. F., & Knapp, P. E. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00294 · Cited by 60
Genome wide association analysis in a mouse advanced intercross line
Gonzales, N. M., Seo, J., Cordero, A. I. H., Pierre, C. L. S., Gregory, J. S., Distler, M. G., Abney, M., Canzar, S., Lionikas, A., & Palmer, A. A. (2018) · Nature Communications · doi:10.1038/s41467-018-07642-8 · Cited by 64
Metadata
- Authors
- Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., Valverde, O., Maldonado, R., & Kieffer, B. L.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Universitat Pompeu Fabra (ES)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Corresponding author
- Kieffer, Brigitte L.
- ORCID
- Venue
- Nature Genetics
- Published
- 2000-06
- Volume
- 25
- Issue
- 2
- Pages
- 195-200
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1505495051
- Cited by
- 672
- References
- 31
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 15 · 2023: 19 · 2022: 18 · 2021: 16 · 2020: 24 · 2019: 29 · 2018: 28 · 2017: 30 · 2016: 41 · 2015: 24 · 2014: 39 · 2013: 35 · 2012: 33
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- delta opioid receptor, mu-opioid receptor, kappa opioid receptor, OprM, anxiety-like behavior, depression-like behavior, emotion regulation, mood disorders, drug addiction, pain
- MeSH terms
- Animals, Anxiety, Binding Sites, Darkness, Depression, Electroshock, Female, Light, Male, Motor Activity, Naloxone, Naltrexone, Narcotic Antagonists, Phenotype, Sex Characteristics, Swimming, Pain Threshold, Gene Deletion, Receptors, Opioid, mu, Receptors, Opioid, delta, Receptors, Opioid, kappa, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.